Latest filing published 26 Sept 2025 for AstraZeneca PLC, €628.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Karen Knudsen: trading record in brief
Karen Knudsen, listed as board member, appears in our data through filings on AstraZeneca PLC shares, published by Finansinspektionen. Over a trading history stretching from 30 April 2025 to 9 September 2025, the count stands at 3 filings.
The open-market record is one-sided, with 3 purchases worth €90k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
A typical purchase (the median) is worth €628. No cluster: in 3 purchases, no other insider of the company bought within 30 days.
The latest filing, published on 26 September 2025, reports an open-market purchase of €628 in AstraZeneca PLC. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 17 days. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Karen Knudsen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9.074 shares@ US$81.04960.7% of flowDepåbevisISIN US0463531089FI:csv-59442227b9a71e1b374eCanonical exit: 8 Dec 2025 (T+90)
- 9.074 shares@ US$81.05030.7% of flowDepåbevisISIN US0463531089FI:A003S640-1Canonical exit: 8 Dec 2025 (T+90)
- 1,400 shares@ US$71.65597.3% of flowDepåbevisISIN US0463531089FI:A003N793-1Canonical exit: 29 Jul 2025 (T+90)
3 of 3 declarations
